Therefore, the ErbB2 oncogene appears to reprogram tumour differentiation so that instead of the histopathologically distinct tumours induced by NCAPH overexpression, the characteristics of infiltrating ductal adenocarcinoma predominated. Here, ERBB2 is linked to invasive ductal breast carcinoma.